Diabetes Medication Safety
-
{
- All
- News
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Berberine vs Metformin: Which Weight Loss Medication Is Actually Safer For Your Liver?
Berberine is a natural bioactive compound, while metformin is a synthetic weight loss medication that can have an individualised impact on your liver. Here is how each of them can impact liver health and why you need to consult a medical professional
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
Weight-loss Drugs Linked To Preterm Birth Risk In Women With Pre-Existing Diabetes
The research analysed data from more than 750,000 pregnancies, making it one of the largest studies to examine this issue so far.
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
New Study Links Popular Diabetes Drugs To Reduced Risk Of Strokes
GLP-1RA drugs may lower risk of deadly subarachnoid haemorrhage strokes in diabetes patients.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
What Happens If You Drink Karela Juice Daily?
While it may be bitter, drinking karela juice daily for a prolonged period can do wonders for your body.
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Berberine vs Metformin: Which Weight Loss Medication Is Actually Safer For Your Liver?
Berberine is a natural bioactive compound, while metformin is a synthetic weight loss medication that can have an individualised impact on your liver. Here is how each of them can impact liver health and why you need to consult a medical professional
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
Weight-loss Drugs Linked To Preterm Birth Risk In Women With Pre-Existing Diabetes
The research analysed data from more than 750,000 pregnancies, making it one of the largest studies to examine this issue so far.
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
New Study Links Popular Diabetes Drugs To Reduced Risk Of Strokes
GLP-1RA drugs may lower risk of deadly subarachnoid haemorrhage strokes in diabetes patients.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
What Happens If You Drink Karela Juice Daily?
While it may be bitter, drinking karela juice daily for a prolonged period can do wonders for your body.
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
